Elago, Honey .
HRN: 23-50-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/31/2023
09/07/2023
IV
500mg
Q8 X 7daysl
Post OP Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes